Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
cpmp/bpwg/282/00
cpmp/ bpwg/ 282/ 00
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
emea/cpmp/bpwg/1089/00
emea/cpmp/bpwg/1089/00
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
arbeitsgruppe blut und plasma (bpwg)
werkgroep bloed en plasma (bpwg)
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
emea/cpmp/bpwg/198/95 rev.
status
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
dokumentennummer emea/cpmp/bpwg/283/00
referentienummer emea/cpmp/bpwg/283/00
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
emea/cpmp/phvwp/bpwg / 2231/99
referentienummer
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
emea/cpmp/bpwg/198/95 rev.1 note
- 04.10.2000 - 19.10.2000 - 19.12.2000 - 62 days
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
cpmp/bpwg/3226/99 cpmp/bpwg/283/00
cpmp/ bpwg/ 3226/ 99 cpmp/ bpwg/ 283/ 00
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
cpmp-ad-hoc-arbeitsgruppe blutprodukte dokumentennummer cpmp/bpwg/2220/99
cpmp ad-hocwerkgroep bloedproducten referentienummer cpmp/ bpwg/ 2220/ 99
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti-d immunoglobulin for intravenous and/or intramuscular use (cpmp/bpwg/574/99)
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti-d immunoglobulin for intravenous and/or intramuscular use (cpmp/bpwg/574/99)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.